Clinical Effectiveness of PAPILOCARE® in Regression of Cervix HPV Cytological Abnormalities (PAPILOBS GR).

NCT06399341 · clinicaltrials.gov ↗

COMPLETED

Status

524

Enrollment

INDUSTRY

Sponsor class

Conditions

Papillomavirus Infections

Interventions

DEVICE: Papilocare vaginal gel

Sponsor

Elpen Pharmaceutical Co. Inc.